About Raptech Pharma Technologies Private Limited
Data last updated:
Raptech Pharma Technologies Private Limited is a private limited company based in Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2018PTC307538. Its GSTIN is 27AAICR8670A1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹50,000. It is led by directors Amrendar Singh and Arati Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 403 Dhwisha Apartment Chsl Plot No. 49 Near Police Headquarter, Maharashtra, India – 410218.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.18 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹23.2 Lakh (net margin 19.7%) and EBITDA of ₹36.94 Lakh (EBITDA margin 31.3%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 72% over five years.
For more details, the company can be reached via its website raptechlabs.com.
Company details
Contact details
Raptech Pharma Technologies Private Limited's registered office is in Maharashtra. Its website is raptechlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 403 Dhwisha Apartment Chsl Plot No. 49 Near Police Headquarter, Maharashtra, India – 410218
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Raptech Pharma Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raptech Pharma Technologies is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Raptech Pharma Technologies Private Limited, buy the company report.
Financials of Raptech Pharma Technologies Private Limited
FY 2025 filings availableRaptech Pharma Technologies Private Limited reported revenue of ₹1.18 Cr (up 223% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 72% over five years, including 223% growth in the latest year. EBITDA rose 274% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.3% | ||||
| Net Profit Margin | 19.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raptech Pharma Technologies Private Limited, buy the company report.
Board of directors of Raptech Pharma Technologies Private Limited
Raptech Pharma Technologies has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amrendar Singh Also directs: Raptech Laboratories Private Limited | Director | 05 Apr 2018 | 8 Years 7 Months | Current |
| Arati Kumar Singh Also directs: Aps Pharmatechnologies Private Limited | Director | 22 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Raptech Pharma Technologies Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ampaliya Chemicals Private Limited | ₹1.22 Cr (FY 2024) | Sanand, Gujarat, India | ||||
| Sanvincare India Private Limited | ₹1.22 Cr (FY 2025) | 7.0% | Bhopal, Madhya Pradesh, India | |||
| Nature Crete Building Adhesives Private Limited | ₹1.21 Cr (FY 2024) | 108.0% | Bangalore, Karnataka, India | |||
| Hikqs Enterprises Private Limited | ₹1.21 Cr (FY 2025) | 259.0% | Haldwani, Uttarakhand, India | |||
| Alchems Private Limited | ₹1.19 Cr (FY 2025) | -14.0% | Pune, Maharashtra, India | |||
| Raptech Pharma Technologies Private Limitedthis company | ₹1.18 Cr (FY 2025) | ₹23.2 Lakh | 19.7% | 223.0% | Maharashtra, India | |
| Dwirayu Pharma Private Limited | ₹1.16 Cr (FY 2025) | 283.0% | Ahmedabad, Gujarat, India | |||
| Nitin Solvents and Adhesives Private Limited | ₹1.16 Cr (FY 2025) | -12.0% | Nagpur, Maharashtra, India | |||
| Shree Vighnahar Chemicals Private Limited | ₹1.16 Cr (FY 2025) | 31.0% | Thane, Maharashtra, India | |||
| Alliant Specialty Chemicals Private Limited | ₹1.16 Cr (FY 2024) | 1.0% | Mumbai, Maharashtra, India | |||
| Saraswati Paints Private Limited | ₹1.14 Cr (FY 2025) | -6.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Raptech Pharma Technologies Private Limited, buy the company report.
Auditor
Raptech Pharma Technologies Private Limited is audited by GUNJA DALAL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUNJA DALAL & CO | FY 2020 | 129915W |
Shareholding
The shareholding of Raptech Pharma Technologies Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Raptech Pharma Technologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Raptech Pharma Technologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raptech Pharma Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raptech Pharma Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR8670A1Z9 | Maharashtra | Active | 26 Apr 2018 |
To see the full GST registrations and return filing status of Raptech Pharma Technologies Private Limited, buy the company report.
Recent activity
Raptech Pharma Technologies Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Arati Kumar Singh was appointed as Director on 22 May 2024.
Frequently asked questions
Raptech Pharma Technologies is an active private limited company based in Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 April 2018 (8+ years old) and is registered under CIN U73100MH2018PTC307538.
Raptech Pharma Technologies has 2 current directors:
- Amrendar Singh - Director
- Arati Kumar Singh - Director
The latest financial statements of Raptech Pharma Technologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Raptech Pharma Technologies is 27AAICR8670A1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Raptech Pharma Technologies is U73100MH2018PTC307538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raptech Pharma Technologies was incorporated on 05 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Raptech Pharma Technologies by revenue are Ampaliya Chemicals Private Limited, Sanvincare India Private Limited, Nature Crete Building Adhesives Private Limited, Hikqs Enterprises Private Limited, Alchems Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Arati Kumar Singh was appointed as Director on 22 May 2024. Rajivkumar Janardanprasad Singh ceased to be Managing Director on 22 May 2024. Amrendar Singh was appointed as Director on 05 Apr 2018.
Raptech Pharma Technologies can be reached through the website raptechlabs.com. Its registered office is in Maharashtra, India.
The registered office of Raptech Pharma Technologies is at Flat No. 403 Dhwisha Apartment Chsl Plot No. 49 Near Police Headquarter, Maharashtra, India – 410218.
Raptech Pharma Technologies operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
